Impaired distribution of α-methyl-L-p-tyrosine in diabetic rats

Brain Research

Volumn 739, Issue 1-2, 1996, Pages 210-214

  Gbadebo, T David ^a   Althaus, John S ^b   Narasimhachari, Nedathur ^c   Stewart, Jennifer K ^c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b PFIZER INC   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

methyl DOPA; methyl norepinephrine; brain; catecholamine; diabetes; epinephrine; rat

Indexed keywords

METHYLDOPA; METIROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CATECHOLAMINERGIC SYSTEM; CONTROLLED STUDY; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALPHA-METHYLTYROSINE; ANIMALS; BRAIN; CATECHOLAMINES; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INHIBITORS; MALE; METHYLTYROSINES; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; TYROSINE 3-MONOOXYGENASE;

EID: 0030580419     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00827-X     Document Type: Article

References (27)

1. [1] Bellush, L.L. and Reid, S.G., Altered behavior and neurochemistry during short-term insulin withdrawal in streptozotocin-induced diabetic rats, Diabetes, 40 (1991) 217-222.
2. [2] Bitar, M.S. and DeSouza, E.B., Diabetes-related changes in brain β adrenoreceptors in rats as assessed by quantitative autoradiography: relationship to hypothalamic norepinephrine metabolism and pituitary-gonadal hormone secretion, J. Pharmacol. Exp. Ther., 254 (1990) 781-785.
3. [3] Brodie, B.B., Costa, E., Dlabac, A., Neff, N.H. and Smookler, H.H., Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines, J. Pharmacol. Exp. Ther., 154 (1966) 493-498.
4. [4] Brosnan, J.T., Forsey, R.G.P. and Brosnan, M.E, Uptake of tyrosine and leucine in vivo by brain of diabetic and control rats, Am. J. Physiol., 247 (1984) C450-C453.
5. [5] Cheeseman, C., Role of intestinal basolateral membrane in absorption of nutrients, Am. J. Physiol., 263 (1992) R482-R488.
6. [6] Chick, W.L., Lavine, R.L. and Like, A.A., Studies in the diabetic mutant mouse. V. Glucose tolerance in mice homozygous and heterozygous for the diabetes (db) gene, Diabetologia, 6 (1970) 257-262.
7. [7] Crandall, E.A. and Fernstrom, J.D., Effect of experimental diabetes on the levels of aromatic and branched-chain amino acids in rat blood and brain, Diabetes, 32 (1983) 222-230.
8. [8] Felice, L.J., Felice, J.D. and Kissinger, P.T., Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography, J. Neurochem., 31 (1978) 1461-1465.
9. [9] Fernstrom, M.H, Volk, E.A. and Fernstrom, J.D., In vivo tyrosine hydroxylation in the diabetic rat retina: effect of tyrosine administration, Brain Res., 298 (1984) 167-170.
10. [10] Ganguly, P.K., Dhalla, K.S., Innes, I.R., Beamish, R.E. and Dhalla, N.S., Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy, Circ. Res., 59 (1986) 684-693.
11. [11] Hart, J.L., Freas, W., McKenzie, J.E. and Muldoon, S.M., Adrenergic nerve function and contractile activity of the caudal artery of the streptozotocin diabetic rat, J. Auton. Nerv. Syst., 25 (1988) 49-57.
12. [12] Kaul, C.L. and Grewal, R.S., Increased urinary excretion of catecholamines and their metabolites in streptozotocin diabetic rat, Pharmacology, 21 (1980) 223-228.
13. [13] Kuhn, C.M., Surwit, R.S. and Feinglos, M.N., Glipizide stimulates sympathetic outflow in diabetes-prone mice, Life Sci., 56 (1995) 661-666.
14. [14] Lackovic, Z., Salkovic, M., Kuci, Z. and Relja, M., Effects of long-lasting diabetes mellitus on rat and human brain monoamines, J. Neurochem., 54 (1990) 143-147.
15. [15] Lucas, P.D. and Qirbi, A., Tissue noradrenaline and the polyol pathway in experimentally diabetic rats, Br. J. Pharmacol., 97(2) (1989) 347-352.
16. [16] Nadeau, A., Tancrede, G., Nguyen, M.-H. and Rousseau-Migneron, S., Effect of physical training on norepinephrine turnover in tissues of normal and diabetic rats, Metabolism, 35 (1986) 25-29.
17. [17] Nagatsu, T., Levitt, M. and Udenfriend, S., Tyrosine hydroxylase the initial step in norepinephrine biosynthesis, J. Biol. Chem., 239 (1964) 2910-2917.
18. [18] Okada, S., Ohshima, K., Onai, T., Umahara, M., Kobayashi, S. and Ishihara, H., A long survived case of malignant pheochromocytoma treated with α-methyl-p-tyrosine and midaglizol (DG-5128), Nippon Gan Chiryo Gakkai Shi, 25 (1990) 1221-1225.
19. [19] Oliver, E.H., Sartin, J.L., Dieberg, G., Rabe, C.H., Marple, D.N. and Kemppainen, R.J., Effects of acute insulin deficiency on catecholamine and indoleamine content and catecholamine turnover in microdissected hypothalamic nuclei in streptozotocin-diabetic rats, Acta Endocrinol., 120 (1989) 343-350.
20. [20] Ostenson, C.G., Hjemdahl, P. and Efendic, S., Release of catecholamines is increased but does not contribute to the impaired insulin secretion in the perfused pancreata of diabetic rats, Pancreas, 8 (1993) 34-38.
21. [21] Steger, R.W. and Kienast, S.G., Effect of continuous versus delayed insulin replacement on sex behavior and neuroendocrine function in diabetic male rats. Diabetes, 39 (1990) 942-948.
22. [22] Stewart, J.K., Campbell, T.G., Gbadebo, T.D., Narasimhachari, N. and Manning, J.W., Cardiovascular responses and central catecholamines in streptozocin-diabetic rats, Neurochem. Int., 24 (1994) 183-189.
23. [23] Thomson, A.B., Cheeseman, C.I., Keelan, M., Fedorak, R. and Clandinin, M., Crypt cell production rate, enterocyte turnover time and appearance of transport along the jejunal villus of the rat, Biochim. Biophys. Acta, 1191 (1994) 197-204.
24. [24] Udenfriend, S., Zaltzman-Nirenberg, P. and Nagatsu, T., Inhibitors of purified beef adrenal tyrosine hydroxylase, Biochem. Pharmacol., 14 (1965) 837-845.
25. [25] Weiner, N., A critical assessment of methods for the determination of monoamine synthesis turnover rates in vivo. In E. Usdin (Ed.), Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes, Raven Press, New York, 1974, pp. 143-159.
26. [26] Yen, T.T., Fuller, R.W., Broderick, C.L., Hemrick-Luecke, S.K. and Perry, K.W., AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats, Res. Commun. Pathol. Pharmacol., 61 (1988) 257-260.
27. [27] Yoshida, T., Nishioka, H., Nakamura, Y. and Kondo, M., Reduced noradrenaline turnover in streptozotocin-induced diabetic rats, Diabetologia, 28 (1985) 692-696.